RVX.TO
Price:
$0.055
Market Cap:
$11.01M
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.[Read more]
Industry
Biotechnology
IPO Date
2004-05-07
Stock Exchange
TSX
Ticker
RVX.TO
According to Resverlogix Corp.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Resverlogix Corp. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RVX.TO's Dividend Yield was at its highest in in the October 2013 quarter at 0%. The Dividend Yield was at its lowest in in the October 2013 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Resverlogix Corp. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Resverlogix Corp. (RVX.TO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Resverlogix Corp.’s Dividend Yield is less than Oncolytics Biotech Inc. (0%), less than Theratechnologies Inc. (0%), less than Microbix Biosystems Inc. (0%), less than Aptose Biosciences Inc. (0%), less than Helix BioPharma Corp. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $123.18M | |
0% | $77.25M | |
0% | $42.74M | |
0% | $9.96M | |
0% | $37.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Resverlogix Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Resverlogix Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Resverlogix Corp.'s Dividend Yield?
How is the Dividend Yield calculated for Resverlogix Corp. (RVX.TO)?
What is the highest Dividend Yield for Resverlogix Corp. (RVX.TO)?
What is the 3-year average Dividend Yield for Resverlogix Corp. (RVX.TO)?
What is the 5-year average Dividend Yield for Resverlogix Corp. (RVX.TO)?
How does the current Dividend Yield for Resverlogix Corp. (RVX.TO) compare to its historical average?